ioana berindan neagoe
ioana berindan neagoe
The Oncology Institute Ion Chiricuta University of Medicine and Pharmacy Iuliu Hatieganu Cluj Napoca
Verified email at umfcluj.ro
Title
Cited by
Cited by
Year
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
H Ling, R Spizzo, Y Atlasi, M Nicoloso, M Shimizu, RS Redis, N Nishida, ...
Genome research 23 (9), 1446-1461, 2013
4762013
MicroRNAome genome: a treasure for cancer diagnosis and therapy
I Berindan‐Neagoe, PC Monroig, B Pasculli, GA Calin
CA: a cancer journal for clinicians 64 (5), 311-336, 2014
3652014
Apoptosis in cancer: key molecular signaling pathways and therapy targets
C Burz, I Berindan-Neagoe, O Balacescu, A Irimie
Acta oncologica 48 (6), 811-821, 2009
2442009
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
D Arango, AJ Wilson, Q Shi, GA Corner, MJ Aranes, C Nicholas, M Lesser, ...
British journal of cancer 91 (11), 1931-1946, 2004
2382004
Junk DNA and the long non-coding RNA twist in cancer genetics
H Ling, K Vincent, M Pichler, R Fodde, I Berindan-Neagoe, FJ Slack, ...
Oncogene 34 (39), 5003-5011, 2015
2372015
Exosomes as divine messengers: are they the Hermes of modern molecular oncology?
C Braicu, C Tomuleasa, P Monroig, A Cucuianu, I Berindan-Neagoe, ...
Cell Death & Differentiation 22 (1), 34-45, 2015
2022015
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
RS Redis, AM Sieuwerts, MP Look, O Tudoran, C Ivan, R Spizzo, X Zhang, ...
Oncotarget 4 (10), 1748, 2013
1642013
Progresses towards safe and efficient gene therapy vectors
S Chira, CS Jackson, I Oprea, F Ozturk, MS Pepper, I Diaconu, C Braicu, ...
Oncotarget 6 (31), 30675, 2015
1572015
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
CS Cătană, IB Neagoe, V Cozma, C Magdaş, F Tăbăran, DL Dumitraşcu
World Journal of Gastroenterology: WJG 21 (19), 5823, 2015
1532015
The relationship between the structure and biological actions of green tea catechins
C Braicu, MR Ladomery, VS Chedea, A Irimie, I Berindan-Neagoe
Food Chemistry 141 (3), 3282-3289, 2013
1172013
Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2
RS Redis, LE Vela, W Lu, JF de Oliveira, C Ivan, C Rodriguez-Aguayo, ...
Molecular cell 61 (4), 520-534, 2016
1072016
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
H Ling, K Pickard, C Ivan, C Isella, M Ikuo, R Mitter, R Spizzo, MD Bullock, ...
Gut 65 (6), 977-989, 2016
1062016
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
C Tomuleasa, O Soritau, A Orza, M Dudea, B Petrushev, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 21 (2), 2012
962012
Molecular pathways: microRNAs, cancer cells, and microenvironment
I Berindan-Neagoe, GA Calin
Clinical cancer research 20 (24), 6247-6253, 2014
872014
Clinical and pathological implications of miRNA in bladder cancer
C Braicu, R Cojocneanu-Petric, S Chira, A Truta, A Floares, B Petrut, ...
International journal of nanomedicine 10, 791, 2015
822015
Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells
C Braicu, CD Gherman, A Irimie, I Berindan-Neagoe
Journal of Nanoscience and Nanotechnology 13 (1), 632-637, 2013
742013
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers
K Van Roosbroeck, F Fanini, T Setoyama, C Ivan, C Rodriguez-Aguayo, ...
Clinical Cancer Research 23 (11), 2891-2904, 2017
732017
Electrochemical immunosensors in breast and ovarian cancer
I Diaconu, C Cristea, V Hârceagă, G Marrazza, I Berindan-Neagoe, ...
Clinica Chimica Acta 425, 128-138, 2013
732013
CRISPR/Cas9: transcending the reality of genome editing
S Chira, D Gulei, A Hajitou, AA Zimta, P Cordelier, I Berindan-Neagoe
Molecular Therapy-Nucleic Acids 7, 211-222, 2017
712017
The new era of nanotechnology, an alternative to change cancer treatment
A Jurj, C Braicu, LA Pop, C Tomuleasa, CD Gherman, I Berindan-Neagoe
Drug design, development and therapy 11, 2871, 2017
682017
The system can't perform the operation now. Try again later.
Articles 1–20